MedPath

Efficacy and Safety of Sequential Sublingual Immunotherapy with Japanese Ceder Pollen and House Dust Mite allergens

Not Applicable
Recruiting
Conditions
allergic rhinitis
Registration Number
JPRN-UMIN000036469
Lead Sponsor
Shiga University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
184
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who can not obtain written research cooperation. Patients who can not confirm their own consent to participate in research. Patients who are judged not to participate in this study by their doctor

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath